α
Conclusion: These results indicate the effectiveness of a2d modulators for management of neuropathic pain secondary to compression radiculopathy. The results also suggest a possible therapeutic superiority of LYRICA over locally available generic brands of pregabalin and gabapentin. These findings need to be further examined in randomized, controlled trials. (Source: Indian Journal of Palliative Care)...
POSTED 03/09/2010 at 11:16 AM --
|
Improving Residents' End-of-Life Communication Skills with a Short Retreat: A Randomized Controlled Trial
Journal of Palliative Medicine , Vol. 0, No. 0. (Source: Journal of Palliative Medicine)...
POSTED 03/04/2010 at 10:03 PM --
|
Advance Care Planning and Hospice Enrollment: Who Really Makes the Decision To Enroll?
Journal of Palliative Medicine , Vol. 0, No. 0. (Source: Journal of Palliative Medicine)...
POSTED 03/04/2010 at 01:14 PM --
|
Can Anti-Infective Drugs Improve the Infection-Related Symptoms of Patients with Cancer During the Terminal Stages of their Lives?
Journal of Palliative Medicine , Vol. 0, No. 0. (Source: Journal of Palliative Medicine)...
POSTED 03/04/2010 at 01:05 PM --
|
Advance Directives and Do-Not-Resuscitate Orders in Patients with Cancer with Metastatic Spinal Cord Compression: Advanced Care Planning Implications
Journal of Palliative Medicine , Vol. 0, No. 0. (Source: Journal of Palliative Medicine)...
POSTED 03/01/2010 at 09:02 PM --
|
Pediatric Palliative Care: Feedback From the Pediatric Intensivist Community.
We report the results of a survey completed in late 2007 of the Section on Critical Care of the American Academy of Pediatrics (AAP). The 102 respondents provided information regarding their clinical and educational experiences, perceived barriers to the provision of palliative care in the intensive care environment, currently available PPC resources, and the usefulness of palliative care specialization in the pediatric intensive care unit.
PMID: 20197556 [PubMed - as supplied by publisher] (Source: The American Journal of Hospice and Palliative Care)...
POSTED 03/01/2010 at 06:00 PM --
|
Nausea and Vomiting in Advanced Cancer.
Authors: Ang SK, Shoemaker LK, Davis MP
Nausea and vomiting are relatively common in advanced cancer and is dreaded more than pain by patients. The history, pattern of nausea and vomiting, associated symptoms, and physical examination provides clues as to etiology and may guide therapy. Continuous severe nausea unrelieved by vomiting is usually caused by medications or metabolic abnormalities, while nausea relieved by vomiting or induced by eating is usually due to gastroparesis, gastric outlet obstruction, or small bowel obstruction. Drug choices are empiric or based on etiology. Metoclopramide has the greatest evidence for efficacy followed by phenothiazines and tropisetron. Corticosteroids have not been effective in randomized trials except in the case of bowel obstruction. Treatmen......
POSTED 03/01/2010 at 06:00 PM --
|
Role of Palliative Low-Molecular-Weight Heparin for Treating Venous Thromboembolism in Patients With Advanced Cancer.
Authors: Tran QN
Patients with cancer are at risk of developing venous thromboembolism ([VTE]; deep venous thrombosis, and pulmonary embolism). Although vitamin K antagonists had originally been used to treat VTE in these patients, low-molecular-weight heparins (LMWH) have been shown to be more effective and safe for patients with cancer-associated thrombosis. In cancer patients with advanced disease where curative therapy is no longer the intent of treatment, continued anticoagulation for VTE for palliative purposes continues to remain a controversial topic as no large randomized trials have been conducted to guide clinicians in this setting. This review summarizes the data available for treating VTE in cancer patients receiving palliative services.
PMID: 20197558 [PubMed - as sup......
POSTED 03/01/2010 at 06:00 PM --
|
Assessment and management of fatigue in neuromuscular disease.
Authors: Lou JS, Weiss MD, Carter GT
Fatigue is a common and potentially debilitating symptom of neuromuscular disease (NMD). Studies show that patients with NMD subjectively report increased levels of fatigue. Laboratory testing has demonstrated that patients with NMD show objective physiological signs of increased fatigue, with both central and peripheral components. To date, no treatment has been proven to be truly effective through evidence-based medicine. Thus, the clinician must use a multimodality approach to treating fatigue in patients with NMD. Management interventions are generally based on a sequential approach including treatment of comorbid factors, with the goal of maximizing physical and psychological functioning. This might include low-intensity exercise training, cogn......
POSTED 02/28/2010 at 06:00 PM --
|
A suicidal patient in the burn unit.
Authors: Baumrucker SJ, Sheldon JE, Stolick M, Oertli KA, Harrington D, Carter G, Morris GM
PMID: 20190204 [PubMed - in process] (Source: The American Journal of Hospice and Palliative Care)...
POSTED 02/28/2010 at 06:00 PM --
|
Book Review: S. L. Ragan, E. M. Wittenberg-Lyles, J. Goldsmith, and S. Sanchez-Reilly. Communication as Comfort: Multiple Voices in Palliative Care. New York: Routledge Publishers. 2008. 184 pp. $34.95. ISBN: 978080585099.
Authors: Miner-Williams D
PMID: 20190205 [PubMed - in process] (Source: The American Journal of Hospice and Palliative Care)...
POSTED 02/28/2010 at 06:00 PM --
|
Bupropion for the Treatment of Neuropathic Pain.
Authors: Shah TH, Moradimehr A
Neuropathic pain is a common problem in clinical practice, affecting patients physically, emotionally, financially, and socially. Current treatment includes antidepressants, antiepileptics, and opioid analgesics. Bupropion is a specific inhibitor of neuronal noradrenaline reuptake and a weak inhibitor of dopamine reuptake, which shows some promise in the treatment of neuropathic pain.
PMID: 20185402 [PubMed - as supplied by publisher] (Source: The American Journal of Hospice and Palliative Care)...
POSTED 02/23/2010 at 06:00 PM --
|
Terminally Ill Schizophrenic Patients: An Ignored Population
Journal of Palliative Medicine Mar 2010, Vol. 13, No. 3: 237-237. (Source: Journal of Palliative Medicine)...
POSTED 02/23/2010 at 04:57 PM --
|
The Plight of a Cancer Patient's Family
Journal of Palliative Medicine Mar 2010, Vol. 13, No. 3: 333-333. (Source: Journal of Palliative Medicine)...
POSTED 02/23/2010 at 04:56 PM --
|
Life in a Hospice: Reflections on Caring for the Dying
Journal of Palliative Medicine Mar 2010, Vol. 13, No. 3: 340-340. (Source: Journal of Palliative Medicine)...
POSTED 02/23/2010 at 04:56 PM --
|
Recent Literature
Journal of Palliative Medicine Mar 2010, Vol. 13, No. 3: 341-342. (Source: Journal of Palliative Medicine)...
POSTED 02/23/2010 at 04:56 PM --
|
Breakthrough Pain
Journal of Palliative Medicine Mar 2010, Vol. 13, No. 3: 345-345. (Source: Journal of Palliative Medicine)...
POSTED 02/23/2010 at 04:56 PM --
|
Announcements
Journal of Palliative Medicine Mar 2010, Vol. 13, No. 3: 347-349. (Source: Journal of Palliative Medicine)...
POSTED 02/23/2010 at 04:56 PM --
|
News and Views
Journal of Palliative Medicine Mar 2010, Vol. 13, No. 3: 231-231. (Source: Journal of Palliative Medicine)...
POSTED 02/23/2010 at 04:56 PM --
|
In this issue
Journal of Palliative Medicine Mar 2010, Vol. 13, No. 3: 229-229. (Source: Journal of Palliative Medicine)...
POSTED 02/23/2010 at 04:56 PM --
|
